MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with C

Conjugated oestrogens

Conjugated oestrogens 1.25mg tablets

No stability information

Stability notes for Conjugated oestrogens 1.25mg tablets

There are no stability notes for this medicine.

Supplier

Conjugated oestrogens 1.25mg tablets (Pfizer Ltd)

Conjugated oestrogens 300microgram tablets

No stability information

Stability notes for Conjugated oestrogens 300microgram tablets

There are no stability notes for this medicine.

Supplier

Conjugated oestrogens 300microgram tablets (Pfizer Ltd)

Conjugated oestrogens 625microgram tablets

No stability information

Stability notes for Conjugated oestrogens 625microgram tablets

There are no stability notes for this medicine.

Supplier

Conjugated oestrogens 625microgram tablets (Pfizer Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.